Obermatt

LifeVantage

NAQ:LFVN · US53222K2050
Personal ProductsSmall

360

33
EV / EBIT9
Price / Owner Earnings23
Owner Earnings Yield55
Dividend Yield1
Price/Sales94
EV / Gross Profit91
Price/Book27
Return on Capital79
Cash Return on Capital84
Return on Equity84
EBIT Margin24
Gross Profitability100
Cash Conversion47
Accruals17
Owner Earnings Margin34
Sales growth7
Profit Growth47
Long-Term EPS Growth1
Owner Earnings Growth13
Reinvestment82
Price momentum35
Debt load68
Refinancing86
Debt Payback100
Liquidity98
Analyst ratings30
Opinion Changes7
Price Target Upside1
Market mood33
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

LifeVantage clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryPersonal Products
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees2,144
ISINUS53222K2050
Last UpdateApr 2, 2026
Themes
CardiovascularLifestyleNutraceuticalDermatologyWellness and RecoveryObesityHealth CareWellness

Description

LifeVantage Corporation (LifeVantage) engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products,…

Analysis

Middle-of-the-road

LifeVantage Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is fair. The owner-earnings multiple stands at 20.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 7% a year, against analyst forecasts of -21%. The market is pricing in far more than analysts expect: heroic expectations.

Growth is weak; the safety picture is adequate. The company scores 10/20 on our value-creation score: creating some value.

Flags to be aware of: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
20
20232026

All-time high

89

Mar 2026

All-time low

20

Jun 2026

Average rank

63

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
94
96
Price/Earnings
17
1
Price/Book
27
48
Dividend Yield
1
98
Value (overall)
21
91

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare LifeVantage with its peers
Corbus Pharmaceuticals Holdings
NAQ:CRBP
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kenvue
NYQ:KVUE
27
CountryUSA
IndustryPersonal Products
SizeX-Large
Full Stock Analysis →
Knife River
NYQ:KNF
6
CountryUSA
IndustryConstruction Materials
SizeLarge
Full Stock Analysis →
VisionWave
NMQ:VWAV
CountryUSA
IndustryAerospace & Defense
SizeX-Small
Full Stock Analysis →
Rhythm Pharmaceuticals
NMQ:RYTM
31
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Verrica Pharmaceuticals
NAQ:VRCA
55
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →